The following is an excerpt from an address on Alternate Therapies for Rare Diseases delivered by Prof Ramaiah Muthyala, President & CEO, IORD at the National Homeopathic Scientific Seminar-2024 in Hyderabad.
Classic Blog Right Sidebar
- Classic Blog Right Sidebar
- Grid Right Sidebar
- Grid Left Sidebar
- Masonry 3 columns
- Masonry 2 columns
- Masonry 4 Columns
- Grid 2 Columns
- Grid 3 Columns
- Grid 4 Columns
- Masonry Left Sidebar
- Masonry Right Sidebar
- Multi Author Right Sidebar
- Multi Author Left Sidebar
- Multi Author Layout
- Masonry Full Width
- Grid Full Width
Registrations are now open for the 12th European Conference on Rare Diseases & Orphan Products (ECRD), scheduled to take place on May 15-16, 2024, at The Square venue in Brussels. Said to be one the largest patient-led events in the rare disease field, the hybrid conference would facilitate collaborative dialogue, learning, and conversation. It servesRead more
The Union Health Ministry has designated Bhopal AIIMS in Madhya Pradesh as a Centre of Excellence (CoE) for treating rare diseases, making it the 12th such hospital in the country under the Rare Disease Policy 2021. The decision was formally taken by the Rare Disease Cell, Union Ministry of Health & Family Welfare (MoHFW), datedRead more
It is with pride that the Indian Organization for Rare Diseases (IORD) observes this welcome development. The entry of Indian pharmaceutical companies into the manufacturing of rare drugs is the result of years of sustained advocacy by IORD and others.
In a boost for rare disease advocacy in India, the Indian government has launched the “National Policy on Research and Development and Innovation in Pharma-MedTech Sector in India” and the “Scheme for Promotion of Research and Innovation in Pharma MedTech Sector (PRIP)”. They focus on fostering research, development, and innovation in the pharmaceutical and medicalRead more